Inactivation as a new regulatory mechanism for neuronal Kv7 channels

Biophysical Journal

Volumn 92, Issue 8, 2007, Pages 2747-2756

  Jensen, Henrik Sindal ^a,c   Grunnet, Morten ^a,b   Olesen, Søren Peter ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEUROSEARCH A S   (Denmark)

^c H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; 3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; POTASSIUM CHANNEL BLOCKING AGENT; RETIGABINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; NONHUMAN; VOLTAGE CLAMP;

EID: 34147192511     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.101287     Document Type: Article

References (59)

1. Robbins, J. 2001. KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol. Ther. 90:1-19.
2. Jentsch, T. J. 2000. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci. 1:21-30.
3. Jespersen, T., M. Grunnet, and S. P. Olesen. 2005. The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda). 20:408-416.
4. Wang, Q., M. E. Curran, I. Splawski, T. C. Burn, J. M. Millholland, T. J. VanRaay, J. Shen, K. W. Timothy, G. M. Vincent, T. de Jager, P. J. Schwartz, J. A. Toubin, A. J. Moss, D. L. Atkinson, G. M. Landes, T. D. Connors, and M. T. Keating. 1996. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12:17-23.
5. Sanguinetti, M. C., M. E. Curran, A. Zou, J. Shen, P. S. Spector, D. L. Atkinson, and M. T. Keating. 1996. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 384:80-83.
6. Barhanin, J., F. Lesage, E. Guillemare, M. Fink, M. Lazdunski, and G. Romey. 1996. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 384:78-80.
7. Brown, D. A., and P. R. Adams. 1980. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature. 283:673-676.
8. Biervert, C., B. C. Schroeder, C. Kubisch, S. F. Berkovic, P. Propping, T. J. Jentsch, and O. K. Steinlein. 1998. A potassium channel mutation in neonatal human epilepsy. Science. 279:403-406.
9. Singh, N. A., C. Charlier, D. Stauffer, B. R. DuPont, R. J. Leach, R. Melis, G. M. Ronen, I. Bjerre, T. Quattlebaum, J. V. Murphy, M. L. McHarg, D. Gagnon, T. O. Rosales, A. Peiffer, V. E. Anderson, and M. Leppert. 1998. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18:25-29.
10. Charlier, C., N. A. Singh, S. G. Ryan, T. B. Lewis, B. E. Reus, R. J. Leach, and M. Leppert. 1998. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18:53-55.
11. Wang, H. S., Z. Pan, W. Shi, B. S. Brown, R. S. Wymore, I. S. Cohen, J. E. Dixon, and D. McKinnon. 1998. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 282:1890-1893.
12. Schroeder, B. C., C. Kubisch, V. Stein, and T. J. Jentsch. 1998. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature (Lond.). 396:687-690.
13. Kubisch, C., B. C. Schroeder, T. Friedrich, B. Lutjohann, A. El Amraoui, S. Marlin, C. Petit, and T. J. Jentsch. 1999. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell (Cambridge, Massachusetts). 96:437-446.
14. Coucke, P. J., P. Van Hauwe, P. M. Kelley, H. Kunst, I. Schatteman, D. Van Velzen, J. Meyers, R. J. Ensink, M. Verstreken, F. Declau, H. Marres, K. Kastury, S. Bhasin, W. T. McGuirt, R. J. H. Smith, C. W. R. J. Cremers, P. Van de Heyning, P. J. Willems, S. D. Smith, and G. Van Camp. 1999. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum. Mol. Genet. 8:1321-1328.
15. Talebizadeh, Z., P. M. Kelley, J. W. Askew, K. W. Beisel, and S. D. Smith. 1999. Novel mutation in the KCNQ4 gene in a large kindred with dominant progressive hearing loss. Hum. Mutat. 14:493-501.
16. Jensen, H. S., K. Callo, T. Jespersen, B. S. Jensen, and S. P. Olesen. 2005. The KCNQ5 potassium channel from mouse: a broadly expressed M-current like potassium channel modulated by zinc, pH, and volume changes. Brain Res. Mol. Brain Res. 139:52-62.
17. Schroeder, B. C., M. Hechenberger, F. Weinreich, C. Kubisch, and T. J. Jentsch. 2000. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J. Biol. Chem. 275:24089-24095.
18. Lerche, C., C. R. Scherer, G. Seebohm, C. Derst, A. D. Wei, A. E. Busch, and K. Steinmeyer. 2000. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J. Biol. Chem. 275:22395-22400.
19. Grunnet, M., T. Jespersen, N. MacAulay, N. K. Jorgensen, N. Schmitt, O. Pongs, S. P. Olesen, and D. A. Klaerke. 2003. KCNQ1 channels sense small changes in cell volume. J. Physiol. 549:419-427.
20. Marx, S. O., J. Kurokawa, S. Reiken, H. Motoike, J. D9Armiento, A. R. Marks, and R. S. Kass. 2002. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 295:496-499.
21. Potet, F., J. D. Scott, R. Mohammad-Panah, D. Escande, and I. Baro. 2001. AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IsK channel complex. Am. J. Physiol. Heart Circ. Physiol. 280:H2038-H2045.
22. Loussouarn, G., K. H. Park, C. Bellocq, I. Baro, F. Charpentier, and D. Escande. 2003. Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J. 22:5412-5421.
23. Peretz, A., H. Schottelndreier, L. B. Aharon-Shamgar, and B. Attali. 2002. Modulation of homomeric and heteromeric KCNQ1 channels by external acidification. J. Physiol. 545:751-766.
24. Unsold, B., G. Kerst, H. Brousos, M. Hubner, R. Schreiber, R. Nitschke, R. Greger, and M. Bleich. 2000. KCNE1 reverses the response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and sensitivity to temperature. Pflugers Arch. 441:368-378.
25. Tinel, N., S. Diochot, M. Borsotto, M. Lazdunski, and J. Barhanin. 2000. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel. EMBO J. 19:6326-6330.
26. Schroeder, B. C., S. Waldegger, S. Fehr, M. Bleich, R. Warth, R. Greger, and T. J. Jentsch. 2000. A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature. 403:196-199.
27. Grunnet, M., T. Jespersen, H. B. Rasmussen, T. Ljungstrom, N. K. Jorgensen, S. P. Olesen, and D. A. Klaerke. 2002. KCNE4 is an inhibitory subunit to the KCNQ1 channel. J. Physiol. 542:119-130.
28. Angelo, K., T. Jespersen, M. Grunnet, M. S. Nielsen, D. A. Klaerke, and S. P. Olesen. 2002. KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current. Biophys. J. 83:1997-2006.
29. Shapiro, M. S., J. P. Roche, E. J. Kaftan, H. Cruzblanca, K. Mackie, and B. Hille. 2000. Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current. J. Neurosci. 20:1710-1721.
30. Simmons, M. A., C. R. Schneider, and J. E. Krause. 1994. Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor. J. Pharmacol. Exp. Ther. 271:581-589.
31. Cruzblanca, H., D. S. Koh, and B. Hille. 1998. Bradykinin inhibits M current via phospholipase C and Ca2+ release from IP3-sensitive Ca2+ stores in rat sympathetic neurons. Proc. Natl. Acad. Sci. USA. 95:7151-7156.
32. Suh, B. C., and B. Hille. 2002. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron. 35:507-520.
33. Zhang, H., L. C. Craciun, T. Mirshahi, T. Rohacs, C. M. Lopes, T. Jin, and D. E. Logothetis. 2003. PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron. 37:963-975.
34. Ford, C. P., P. L. Stemkowski, P. E. Light, and P. A. Smith. 2003. Experiments to test the role of phosphatidylinositol 4,5-bisphosphate in neurotransmitter-induced M-channel closure in bullfrog sympathetic neurons. J. Neurosci. 23:4931-4941.
35. Delmas, P., and D. A. Brown. 2005. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat. Rev. Neurosci. 6:850-862.
36. Hougaard, C., D. A. Klaerke, E. K. Hoffmann, S. P. Olesen, and N. K. Jorgensen. 2004. Modulation of KCNQ4 channel activity by changes in cell volume. Biochim. Biophys. Acta. 1660:1-6.
37. Seebohm, G., N. Strutz-Seebohm, R. Baltaev, G. Korniychuk, M. Knirsch, J. Engel, and F. Lang. 2005. Regulation of KCNQ4 potassium channel prepulse dependence and current amplitude by SGK1 in Xenopus oocytes. Cell. Physiol. Biochem. 16:255-262.
38. Tristani-Firouzi, M., and M. C. Sanguinetti. 1998. Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits. J. Physiol. 510:37-45.
39. Seebohm, G., C. R. Scherer, A. E. Busch, and C. Lerche. 2001. Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome. J. Biol. Chem. 276:13600-13605.
40. Grunnet, M., S. P. Olesen, D. A. Klaerke, and T. Jespersen. 2005. hKCNE4 inhibits the hKCNQ1 potassium current without affecting the activation kinetics. Biochem. Biophys. Res. Commun. 328:1146-1153.
41. Schroder, R. L., D. Strobaek, S. P. Olesen, and P. Christophersen. 2003. Voltage-independent KCNQ4 currents induced by (±)BMS-204352. Pflugers Arch. 446:607-616.
42. Bentzen, B. H., N. Schmitt, K. Calloe, B. W. Dalby, M. Grunnet, and S. P. Olesen. 2006. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels. Neuropharmacology. 51:1068-1077.
43. Tatulian, L., and D. A. Brown. 2003. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J. Physiol. 549:57-63.
44. Tatulian, L., P. Delmas, F. C. Abogadie, and D. A. Brown. 2001. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 21:5535-5545.
45. Gribkoff, V. K., J. E. Starrett Jr., S. I. Dworetzky, P. Hewawasam, C. G. Boissard, D. A. Cook, S. W. Frantz, K. Heman, J. R. Hibbard, K. Huston, G. Johnson, B. S. Krishnan, G. G. Kinney, L. A. Lombardo, N. A. Meanwell, P. B. Molinoff, R. A. Myers, S. L. Moon, A. Ortiz, L. Pajor, R. L. Pieschl, D. J. Post-Munson, L. J. Signor, N. Srinivas, M. T. Taber, G. Thalody, J. T. Trojnacki, H. Wiener, K. Yeleswaram, and S. W. Yeola. 2001. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat. Med. 7:471-477.
46. Dupuis, D. S., R. L. Schroder, T. Jespersen, J. K. Christensen, P. Christophersen, B. S. Jensen, and S. P. Olesen. 2002. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. Eur. J. Pharmacol. 437:129-137.
47. Schroder, R. L., T. Jespersen, P. Christophersen, D. Strobaek, B. S. Jensen, and S. P. Olesen. 2001. KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology. 40:888-898.
48. Pusch, M., R. Magrassi, B. Wollnik, and F. Conti. 1998. Activation and inactivation of homomeric KvLQT1 potassium channels. Biophys. J. 75:785-792.
49. Romey, G., B. Attali, C. Chouabe, I. Abitbol, E. Guillemare, J. Barhanin, and M. Lazdunski. 1997. Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity. J. Biol. Chem. 272:16713-16716.
50. Korsgaard, M. P., B. P. Hartz, W. D. Brown, P. K. Ahring, D. Strobaek, and N. R. Mirza. 2005. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J. Pharmacol. Exp. Ther. 314:282-292.
51. Dalby-Brown, W., H. H. Hansen, M. P. Korsgaard, N. Mirza, and S. P. Olesen. 2006. K(v)7 channels: function, pharmacology and channel modulators. Curr. Top. Med. Chem. 6:999-1023.
52. Li, Y., N. Gamper, and M. S. Shapiro. 2004. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent. J. Neurosci. 24:5079-5090.
53. Selyanko, A. A., J. K. Hadley, and D. A. Brown. 2001. Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells. J. Physiol. 534:15-24.
54. Roux, M. J., R. Olcese, L. Toro, F. Bezanilla, and E. Stefani. 1998. Fast inactivation in Shaker K+ channels. Properties of ionic and gating currents. J. Gen. Physiol. 111:625-638.
55. Hoshi, T., W. N. Zagotta, and R. W. Aldrich. 1990. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science. 250:533-538.
56. Rettig, J., S. H. Heinemann, F. Wunder, C. Lorra, D. N. Parcej, J. O. Dolly, and O. Pongs. 1994. Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit. Nature. 369:289-294.
57. Liu, Y., M. E. Jurman, and G. Yellen. 1996. Dynamic rearrangement of the outer mouth of a K+ channel during gating. Neuron. 16:859-867.
58. Hansen, H. H., C. Ebbesen, C. Mathiesen, P. Weikop, L. C. Ronn, O. Waroux, J. Scuvee-Moreau, V. Seutin, and J. D. Mikkelsen. 2006. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. J. Pharmacol. Exp. Ther. 318:1006-1019.
59. Kharkovets, T., J. P. Hardelin, S. Safieddine, M. Schweizer, A. El Amraoui, C. Petit, and T. J. Jentsch. 2000. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. USA. 97:4333-4338.